Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
about
sameAs
Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoterProstate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancerMinimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)Inhibition of tumor cell motility by the interferon-inducible GTPase MxAGrowth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibodyGenetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancerAssociation of a common genetic variant in prostate stem cell antigen with cancer risk.Prostate stem cell antigen: a Jekyll and Hyde molecule?Characterization and function of human Ly-6/uPAR molecules.Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study.Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals.Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder.Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells.Genetic susceptibility to bladder cancer risk and outcome.Gene expression in the normal adult human kidney assessed by complementary DNA microarrayOncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients.Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancerPhase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trialPSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells.Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.Prostate stem cell antigen: a prospective therapeutic and diagnostic target.Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumorsClinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens.Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population.An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis.PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.
P2860
Q24531312-2B563475-01A7-4734-8C7F-BF733CE32EFDQ24791973-CD186756-AA2B-4EF4-834E-2EBAD03B18FFQ28652074-8AE9F0ED-463C-49C6-AE23-B821C1F2CB8AQ30487769-2E3CC932-7E16-4022-B00D-7A885678A864Q33550600-3C81098A-7F27-40BC-AA16-678C31EE8E5EQ33738280-0F66AA89-74FA-4088-9460-A6A4E185B58AQ33768683-CF7D3635-6EE1-41E6-9DA7-6361CBAF89BDQ33935316-475241BD-EF46-4AB2-96D1-A28DDFD10E2BQ34001130-E78BE60F-555D-4504-B157-BD6ACCBC11FEQ34314038-DA864BB5-4554-49DB-9554-372E3DE906C7Q34348466-65931983-74E4-4286-80C2-31595A31E089Q34543335-CD637739-60F2-4441-8E60-CB99DC4FDA1AQ34993937-774492FE-1DD4-484B-A770-A65D0CD1D90BQ35082285-978324C8-AA20-4BE7-9BD9-15C71222C7F0Q35212792-A19739E1-2FF1-4A92-A657-6F4B6B853360Q35799605-00A5674C-4591-488E-AB2A-A72BF81E8463Q35827735-A389131B-C112-4DF9-AF97-050C08643139Q35855955-17DB2283-2C5C-4586-966F-1847E3DED201Q36278113-513686C2-A1E9-4CF8-B3CF-A9B5986C671FQ36507544-4A2A3186-C1AA-4671-B04D-075FC02FCED4Q36650373-CEE5E1C0-45C1-4793-8441-ED32599AF8F4Q36713618-1ECA54C5-B226-40CA-952C-7CDA77EAC619Q36754909-922B67C3-6BF5-44B6-8603-ADF82E029D5AQ37007328-4BFB09AC-6D88-4302-998B-63D205E86622Q37026797-117E5456-E083-42F1-80CD-1A8351B1F665Q37104978-772C2663-91D5-421C-B13D-FD6EFEDD6141Q37186552-9B08204F-1410-4A16-824E-EB9DC139E7CBQ37289040-AB721E27-0743-4048-BF56-9704813EFB17Q37903072-B21C0A11-9B52-4047-AC57-26983B724055Q38639727-9C080903-BEF3-40B8-AE76-8FD785BB787BQ38711222-7EA709BF-45D0-415F-8C43-8A7F92A5FD4CQ39720680-A9857C0D-CE0A-4CCE-AA5D-ACFBE45D6137Q41551352-BE2EADC2-7F13-475D-B1BB-FED57E5F831DQ41613017-E46F873B-124D-402B-8776-B9D5BF173339Q54989451-63F4BAF6-B596-4863-9884-26E62F4041C1
P2860
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@ast
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@en
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@nl
type
label
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@ast
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@en
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@nl
prefLabel
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@ast
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@en
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@nl
P2093
P3181
P1433
P1476
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
@en
P2093
G S Palapattu
G V Thomas
R E Reiter
P304
P3181
P407
P577
2001-06-15T00:00:00Z